Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 319
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03920579 | A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers | ||
| NCT01340248 | A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers | ||
| NCT07404735 | A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846 | ||
| NCT05931224 | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy | ||
| NCT01330563 | Drug-drug Interaction Study (CKD-501, Ketoconazole) | ||
| NCT06942156 | Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea | ||
| NCT02548286 | Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs | ||
| NCT01369472 | Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule | ||
| NCT01028859 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | ||
| NCT03067194 | The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients | ||
| NCT06044493 | MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients | ||
| NCT03210649 | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT01071720 | The Effect of Food on the Pharmacokinetic Characteristics of CKD-501 | ||
| NCT02648854 | Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers | ||
| NCT03641352 | The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes | ||
| NCT07215637 | Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors | ||
| NCT04700709 | Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. | ||
| NCT04667975 | The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy | ||
| NCT01246193 | CKD-828(80/2.5mg) Pharmacokinetic Study | ||
| NCT03150316 | CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma | ||
| NCT04204603 | A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate | ||
| NCT05108038 | A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects | ||
| NCT05749861 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5) | ||
| NCT04304547 | Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers | ||
| NCT03609606 | A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects | ||
| NCT03950843 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation | ||
| NCT02247518 | CKD-397 Drug-drug Interaction Study (A) | ||
| NCT03067415 | Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily | ||
| NCT02777723 | Study to Evaluate the Efficacy and Safety of CKD-350 | ||
| NCT03536780 | Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment | ||
| NCT01243775 | BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC | ||
| NCT04840745 | The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1 | ||
| NCT05587699 | The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A | ||
| NCT05544214 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects | ||
| NCT02498509 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 | ||
| NCT05719155 | Pharmacokinetics and Safety/Tolerability of CKD-379 | ||
| NCT05041790 | A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment | ||
| NCT04448223 | A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 | ||
| NCT04478097 | Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers | ||
| NCT02247505 | CKD-397 Drug-drug Interaction Study (B) | ||
| NCT05677438 | A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia | ||
| NCT05704621 | Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance | ||
| NCT06430047 | Efficacy and Safety of EsoDuo® | ||
| NCT01133431 | The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea | ||
| NCT03739125 | Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes | ||
| NCT03849495 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults | ||
| NCT06431477 | Efficacy and Safety of Telmisartan Compared With Losartan | ||
| NCT03849339 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition | ||
| NCT03076957 | A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj. | ||
| NCT02651870 | Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy |
